Compare LENZ & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | QUCY |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.8M | 86.6M |
| IPO Year | 2021 | 2021 |
| Metric | LENZ | QUCY |
|---|---|---|
| Price | $4.04 | $0.57 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 347.4K |
| Earning Date | 10-28-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.68 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | $537,080.00 |
| Revenue This Year | N/A | $281.69 |
| Revenue Next Year | $125.50 | $123.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.80 | $0.30 |
| 52 Week High | $32.13 | $4.93 |
| Indicator | LENZ | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 24.24 |
| Support Level | $3.60 | $0.42 |
| Resistance Level | $6.11 | $0.69 |
| Average True Range (ATR) | 0.38 | 0.09 |
| MACD | 0.14 | -0.01 |
| Stochastic Oscillator | 77.71 | 1.95 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.